| Second Street Health Center | |
|
60 Second St Auburn ME 04210-6853 | |
| (207) 755-3456 | |
| (207) 755-3457 |
| Full Name | Second Street Health Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 60 Second St, Auburn, Maine |
| Authorized Official Name and Position | Coleen L Elias (CEO/CFO) |
| Authorized Official Contact | 2075133897 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Second Street Health Center Po Box 95000 Lbx 7660 Philadelphia PA 19195-0001 Ph: (207) 777-8202 | Second Street Health Center 60 Second St Auburn ME 04210-6853 Ph: (207) 755-3456 |
| NPI Number | 1487080958 |
|---|---|
| Provider Enumeration Date | 09/17/2013 |
| Last Update Date | 10/22/2020 |
| Medicare PECOS PAC ID | 0042101099 |
|---|---|
| Medicare Enrollment ID | O20220128001646 |
News Archive
John Howell, CEO of Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today formally commented on the anticipated timeline for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development - the rights to which have been assigned exclusively to the Company by Arrayit Corporation.
Pursuant to the 8K filing by Sport Endurance, Inc., the Company announced today that it has entered into a letter of intent to acquire S&T Distributors, a Company currently generating in excess of $2,000,000 in annual revenues, with NOI of approximately 30% from its primary business of distributing food and beverage products throughout the Southwest.
One Lambda Inc., a leading manufacturer and supplier of quality products and technology for the HLA transplant community, and Luminex Corporation have agreed to a long-term renewal of their 10-year strategic partnership aimed at developing platforms and technologies for human leukocyte antigen (HLA).
Scientists from Duke-NUS Medical School have derived a structural model of a transporter at the blood-brain barrier called Mfsd2a. This is the first molecular model of this critical transporter, and could prove important for the development of therapeutic agents that need to be delivered to the brain -- across the blood-brain barrier. In future, this could help treat neurological disorders such as glioblastoma.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487080958 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
John Howell, CEO of Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today formally commented on the anticipated timeline for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development - the rights to which have been assigned exclusively to the Company by Arrayit Corporation.
Pursuant to the 8K filing by Sport Endurance, Inc., the Company announced today that it has entered into a letter of intent to acquire S&T Distributors, a Company currently generating in excess of $2,000,000 in annual revenues, with NOI of approximately 30% from its primary business of distributing food and beverage products throughout the Southwest.
One Lambda Inc., a leading manufacturer and supplier of quality products and technology for the HLA transplant community, and Luminex Corporation have agreed to a long-term renewal of their 10-year strategic partnership aimed at developing platforms and technologies for human leukocyte antigen (HLA).
Scientists from Duke-NUS Medical School have derived a structural model of a transporter at the blood-brain barrier called Mfsd2a. This is the first molecular model of this critical transporter, and could prove important for the development of therapeutic agents that need to be delivered to the brain -- across the blood-brain barrier. In future, this could help treat neurological disorders such as glioblastoma.
› Verified 7 days ago
Central Maine Orthopaedics, P.a. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 690 Minot Ave, Suite One, Auburn, ME 04210 Phone: 207-783-1328 Fax: 207-795-0260 | |
Sweet Song Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 249 Old Danville Rd, Auburn, ME 04210 Phone: 207-240-7543 | |
Ccs Behavioral At Cmcc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1250 Turner St, Auburn, ME 04210 Phone: 207-755-3434 | |
Ccs Behavioral At Laim Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3 Willow Run, Room A, Auburn, ME 04210 Phone: 207-795-6800 Fax: 207-795-6140 | |
Auburn Middle School Based Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 38 Falcon Dr, Auburn, ME 04210 Phone: 207-783-3984 Fax: 207-784-1358 | |
Ccs Behavioral At Ren School Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 15 Sacred Heart Pl, Room A, Auburn, ME 04210 Phone: 207-777-4175 Fax: 207-786-2221 |